Latest Breaking News On - Zhanguo li - Page 1 : comparemela.com

Deucravacitinib and Orelabrutinib Perform Well in Lupus Trials

Disease activity was reduced by treatment with either of the novel investigational agents in two separate early clinical trials, with further trials planned.

South australiaUnited statesEli lillyAlbert royEricf morandBristol myers squibbZhanguo liSchool of clinical sciences at monash universityLupus research allianceLupus clinical investigators networkEuropean congressLeeds england institute of rheumaticUniversity people hospitalClinical sciencesMonash universityMusculoskeletal medicine

InnoCare Pharma: Latest Data of InnoCare s Orelabrutinib for the Treatment of SLE Presented at LBA Session of EULAR 2022

InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib for the treatment of Systemic

United statesHong kongChunhua luInnocare pharmaZhanguo liEuropean congressChina national medical products administrationNational reimbursement drugDrug administrationSystemic lupus erythematosusOral presentationBreakthrough therapy designationMultiple sclerosisPrimary immune thrombocytopeniaNeuromyelitis optica spectrum disorder

Latest Data of InnoCare s Orelabrutinib for the Treatment of SLE Presented at LBA Session of EULAR 2022

Latest Data of InnoCare s Orelabrutinib for the Treatment of SLE Presented at LBA Session of EULAR 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongChunhua luInnocare pharmaZhanguo liEuropean congressChina national medical products administrationNational reimbursement drugDrug administrationWall streetCare pharmaSystemic lupus erythematosusOral presentationBreakthrough therapy designationMultiple sclerosisPrimary immune thrombocytopenia

Stock Market | Daily Herald

Stock Market | Daily Herald
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongInnocare pharmaZhanguo liEuropean congressChina national medical products administrationNational reimbursement drugDrug administrationSystemic lupus erythematosusOral presentationBreakthrough therapy designationMultiple sclerosisPrimary immune thrombocytopeniaNeuromyelitis optica spectrum disorder

Conflict between efficacy and economy in rheumatoid arthritis treatment: Iguratimod is found at a compromise

Conflict between efficacy and economy in rheumatoid arthritis treatment: Iguratimod is found at a compromise
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Novartis pharmaBristol myers squibbMasao tamalaZhanguo liAsahi kasei pharma corpChugai pharmaceutical co ltdAmerican college of rheumatologyTaisho pharma co ltdEisai co ltdJapan co ltdJapan co ltd masao tanakaAstellas pharma incPfizer incMitsubishi tanabe pharma corpTanabe pharma corpAyumi pharmaceutical corp